Selective effects of thiol reagents on the binding sites for imipramine and neurotransmitter amines in the rat brain.
The action of the antithyroid drugs methimazole (MMI) and propylthiouracil (PTU) on the binding of [3H]-imipramine, [3H]-5-hydroxytryptamine [3H]-5-HT) (to 5-HT1-receptors) and [3H]-spiperone (to 5-HT2-, D2-receptors) of rat brain membranes has been examined. The synaptosomal uptake of [3H]-5-HT was also studied. Micromolar concentrations of the disulphide bond reducing agents MMI, PTU, dithiothreitol (DTT) and mercaptoethanol increased both the binding of [3H]-imipramine and the uptake of [3H]-5-HT. In contrast, they decreased the number of 5-HT1-receptors, and did not affect 5-HT2-and D2-sites. Reaction with membrane-bound sulphydryl (SH) groups by micromolar concentrations of N-ethylmaleimide (NEM), hydroxymercuribenzoic acid (PCMB), or Ellman's reagent (DTNB) decreased the binding of [3H]-imipramine, the number of 5-HT1-receptors, and the uptake of [3H]-5-HT. Millimolar concentrations of NEM were necessary in order to decrease partially 5-HT2- and D2-receptors. The effects of NEM on imipramine recognition sites and on the uptake of 5-HT could be prevented by DTT; protection was not obtained in other receptor systems. Three groups of receptors have been, thus, postulated, based upon their different sensitivity towards alterations in membrane [disulphide bridges in equilibrium SH] equilibrium: Group I, including imipramine recognition sites and the uptake system for 5-HT; Group II, including 5-HT1-receptors; Group III, including 5-HT2-and D2-receptors.
Biassoni
R
R
Vaccari
A
A
D000818:Animals; D001921:Brain / Q000378:metabolism*; D002352:Carrier Proteins; D004228:Dithionitrobenzoic Acid / Q000494:pharmacology; D004229:Dithiothreitol / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D006902:Hydroxymercuribenzoates / Q000494:pharmacology; D007099:Imipramine / Q000378:metabolism; D008297:Male; D008623:Mercaptoethanol / Q000494:pharmacology; D008713:Methimazole / Q000494:pharmacology; D011441:Propylthiouracil / Q000494:pharmacology; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism*; D011955:Receptors, Drug; D017981:Receptors, Neurotransmitter / Q000187:drug effects / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism; D013134:Spiperone / Q000378:metabolism; D013439:Sulfhydryl Reagents / Q000494:pharmacology*
D002352:Carrier Proteins; D006902:Hydroxymercuribenzoates; D011954:Receptors, Dopamine; D011955:Receptors, Drug; D017981:Receptors, Neurotransmitter; D013439:Sulfhydryl Reagents; C027775:imipramine receptor; C030601:4-hydroxymercuribenzoate; D012701:Serotonin; D013134:Spiperone; D008713:Methimazole; D008623:Mercaptoethanol; D011441:Propylthiouracil; D004228:Dithionitrobenzoic Acid; D005033:Ethylmaleimide; D007099:Imipramine; D004229:Dithiothreitol